Devlin Jodi 4
4 · TriSalus Life Sciences, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Devlin Jodi
Chief of Clinical Operations
Transactions
- Award
Common Stock
2025-02-18+5,272→ 33,397 total
Footnotes (1)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.